mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.02 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.03 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.03 |